Original Research
Published on 20 Apr 2021
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.641975
- 6,945 views
- 5 citations
